Furthermore, NPTX2 in CSF was the only biomarker that was associated significantly with MMSE score in AD patients, outperforming previously established biomarkers (e.g., p‐Tau181), which serves as evidence of its robustness as a cognitive impairment marker. Here, NPTX2 is linked to Cognitive impairment.